Bruce Linton Speaks Out About Creso, Red Light Holland, and The HighBrid Lab

Investors may have gotten a surprise when Creso Pharma (ASX: CPH) and Red Light Holland Corp (CNSX: TRIP) (OTCMKTS: TRUFF) announced plans to merge into one entity, creating one global psychedelics and cannabinoid company called The HighBrid Lab. The merged entity, as per the news release, is expected to have a pro-forma equity value of $347 million and with a cash balance of approximately C$45 million. Strategic advisor Bruce Linton is here today with us on The Dales Report to discuss why HighBrid is great news for investors, and what we might see in the future coming from this new merger. Here’s some highlights from the interview: - HighBrid gets Creso off the ASX - The HighBrid Labs will be a place where science, fun, and the grey zone of business “come together” says Linton - Linton feels that investors in HighBrid will be excited by these benefits About Channel: We are a business news platform that provides the latest and best insight on the stories making headlines around the world. We give Institutional and retail investors an inside edge in the competitive world of investing and profile companies that are making waves in their ever-growing industries. We are The Dales Report. Check out our website: https://thedalesreport.com/​​ Subscribe to our channel at https://article.thedalesreport.com/yo...​ Connect with us on our social media handles: Twitter: https://twitter.com/TheDalesReport​​ Instagram: https://www.instagram.com/thedalesrep...​ Tiktok: https://www.tiktok.com/@thedalesrepor...​ Facebook: https://www.facebook.com/thedalesreport​